KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Moderna (MRNA) Profit After Tax: 2017-2025

Historic Profit After Tax for Moderna (MRNA) over the last 8 years, with Sep 2025 value amounting to -$200.0 million.

  • Moderna's Profit After Tax fell 1638.46% to -$200.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.1 billion, marking a year-over-year decrease of 40.11%. This contributed to the annual value of -$3.6 billion for FY2024, which is 24.46% up from last year.
  • Per Moderna's latest filing, its Profit After Tax stood at -$200.0 million for Q3 2025, which was up 75.76% from -$825.0 million recorded in Q2 2025.
  • Moderna's 5-year Profit After Tax high stood at $4.9 billion for Q4 2021, and its period low was -$3.6 billion during Q3 2023.
  • In the last 3 years, Moderna's Profit After Tax had a median value of -$971.0 million in 2025 and averaged -$933.7 million.
  • Its Profit After Tax has fluctuated over the past 5 years, first skyrocketed by 2,476.07% in 2021, then tumbled by 1,638.46% in 2025.
  • Moderna's Profit After Tax (Quarterly) stood at $4.9 billion in 2021, then crashed by 69.91% to $1.5 billion in 2022, then crashed by 85.19% to $217.0 million in 2023, then slumped by 616.13% to -$1.1 billion in 2024, then slumped by 1,638.46% to -$200.0 million in 2025.
  • Its Profit After Tax was -$200.0 million in Q3 2025, compared to -$825.0 million in Q2 2025 and -$971.0 million in Q1 2025.